These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21811815)

  • 21. Genetic contribution of GADD45A to susceptibility to sporadic and non-BRCA1/2 familial breast cancers: a systematic evaluation in Chinese populations.
    Yu KD; Di GH; Li WF; Rao NY; Fan L; Yuan WT; Hu Z; Wu J; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2010 May; 121(1):157-67. PubMed ID: 19728081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51.
    Silva SN; Tomar M; Paulo C; Gomes BC; Azevedo AP; Teixeira V; Pina JE; Rueff J; Gaspar JF
    Cancer Epidemiol; 2010 Feb; 34(1):85-92. PubMed ID: 20004634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a comprehensive spectrum of genetic factors for hereditary breast cancer in a Chinese population by next-generation sequencing.
    Yang X; Wu J; Lu J; Liu G; Di G; Chen C; Hou Y; Sun M; Yang W; Xu X; Zhao Y; Hu X; Li D; Cao Z; Zhou X; Huang X; Liu Z; Chen H; Gu Y; Chi Y; Yan X; Han Q; Shen Z; Shao Z; Hu Z
    PLoS One; 2015; 10(4):e0125571. PubMed ID: 25927356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer risk associated with genes encoding DNA repair MRN complex: a study from Punjab, Pakistan.
    Khan RT; Siddique A; Shahid N; Khokher S; Fatima W
    Breast Cancer; 2018 May; 25(3):350-355. PubMed ID: 29368209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germline 657del5 mutation in the NBS1 gene in breast cancer patients.
    Górski B; Debniak T; Masojć B; Mierzejewski M; Medrek K; Cybulski C; Jakubowska A; Kurzawski G; Chosia M; Scott R; Lubiński J
    Int J Cancer; 2003 Sep; 106(3):379-81. PubMed ID: 12845677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation analysis of the BCCIP gene for breast cancer susceptibility in breast/ovarian cancer families.
    Bonache S; Gutierrez-Enriquez S; Tenés A; Masas M; Balmaña J; Diez O
    Gynecol Oncol; 2013 Nov; 131(2):460-3. PubMed ID: 23911796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
    Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP
    Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germline variants in MRE11/RAD50/NBN complex genes in childhood leukemia.
    Mosor M; Ziółkowska-Suchanek I; Nowicka K; Dzikiewicz-Krawczyk A; Januszkiewicz-Lewandowska D; Nowak J
    BMC Cancer; 2013 Oct; 13():457. PubMed ID: 24093751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germline NBS1 mutations in families with aggregation of Breast and/or ovarian cancer from north-east Poland.
    Kanka C; Brozek I; Skalska B; Siemiatkowska A; Limon J
    Anticancer Res; 2007; 27(4C):3015-8. PubMed ID: 17695489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ten genes for inherited breast cancer.
    Walsh T; King MC
    Cancer Cell; 2007 Feb; 11(2):103-5. PubMed ID: 17292821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haplotypic variation in MRE11, RAD50 and NBS1 and risk of non-Hodgkin's lymphoma.
    Rollinson S; Kesby H; Morgan GJ
    Leuk Lymphoma; 2006 Dec; 47(12):2567-83. PubMed ID: 17169801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations predisposing to breast cancer in 12 candidate genes in breast cancer patients from Poland.
    Cybulski C; Lubiński J; Wokołorczyk D; Kuźniak W; Kashyap A; Sopik V; Huzarski T; Gronwald J; Byrski T; Szwiec M; Jakubowska A; Górski B; Dębniak T; Narod SA; Akbari MR
    Clin Genet; 2015 Oct; 88(4):366-70. PubMed ID: 25330149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India.
    Saxena S; Chakraborty A; Kaushal M; Kotwal S; Bhatanager D; Mohil RS; Chintamani C; Aggarwal AK; Sharma VK; Sharma PC; Lenoir G; Goldgar DE; Szabo CI
    BMC Med Genet; 2006 Oct; 7():75. PubMed ID: 17018160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Candidate gene analysis of BRCA1/2 mutation-negative high-risk Russian breast cancer patients.
    Sokolenko AP; Preobrazhenskaya EV; Aleksakhina SN; Iyevleva AG; Mitiushkina NV; Zaitseva OA; Yatsuk OS; Tiurin VI; Strelkova TN; Togo AV; Imyanitov EN
    Cancer Lett; 2015 Apr; 359(2):259-61. PubMed ID: 25619955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline and somatic mutations in homologous recombination genes among Chinese ovarian cancer patients detected using next-generation sequencing.
    Zhao Q; Yang J; Li L; Cao D; Yu M; Shen K;
    J Gynecol Oncol; 2017 Jul; 28(4):e39. PubMed ID: 28541631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The MRE11/RAD50/NBS1 complex destabilization in Lynch-syndrome patients.
    Alemayehu A; Fridrichova I
    Eur J Hum Genet; 2007 Sep; 15(9):922-9. PubMed ID: 17534377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational inactivation of the nijmegen breakage syndrome gene (NBS1) in glioblastomas is associated with multiple TP53 mutations.
    Watanabe T; Nobusawa S; Lu S; Huang J; Mittelbronn M; Ohgaki H
    J Neuropathol Exp Neurol; 2009 Feb; 68(2):210-5. PubMed ID: 19151620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility.
    Heikkinen K; Karppinen SM; Soini Y; Mäkinen M; Winqvist R
    J Med Genet; 2003 Dec; 40(12):e131. PubMed ID: 14684699
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of RAD50 in familial breast cancer predisposition.
    Tommiska J; Seal S; Renwick A; Barfoot R; Baskcomb L; Jayatilake H; Bartkova J; Tallila J; Kaare M; Tamminen A; Heikkilä P; Evans DG; Eccles D; Aittomäki K; Blomqvist C; Bartek J; Stratton MR; Nevanlinna H; Rahman N
    Int J Cancer; 2006 Jun; 118(11):2911-6. PubMed ID: 16385572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of germline genetic mutations in patients with pancreatic cancer.
    Salo-Mullen EE; O'Reilly EM; Kelsen DP; Ashraf AM; Lowery MA; Yu KH; Reidy DL; Epstein AS; Lincoln A; Saldia A; Jacobs LM; Rau-Murthy R; Zhang L; Kurtz RC; Saltz L; Offit K; Robson ME; Stadler ZK
    Cancer; 2015 Dec; 121(24):4382-8. PubMed ID: 26440929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.